Literature DB >> 2404203

Paralysis agitans and levodopa in "Ayurveda": ancient Indian medical treatise.

B V Manyam1.   

Abstract

Neurologic diseases (Vata rogas, Sanskrit) and the pharmacologic treatment of them were described in the ancient Indian medical system--Ayurveda. This article explores paralysis agitans, which was described under the name Kampavata. Mucuna pruriens (Atmagupta, Sanskrit), which contains levodopa, was used in the treatment of Kampavata. Existence of paralysis agitans prior to the industrial revolution is not just of historical interest, but would also suggest that under the hypothesis of exposure to environmental toxins as a possible cause of paralysis agitans, natural organic compounds with worldwide distribution should also be considered.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2404203     DOI: 10.1002/mds.870050112

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  17 in total

Review 1.  The Parkinson disease before James Parkinson.

Authors:  Francesco Raudino
Journal:  Neurol Sci       Date:  2011-10-18       Impact factor: 3.307

Review 2.  How far are we in understanding the cause of Parkinson's disease?

Authors:  Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

3.  A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias.

Authors:  Christopher A Lieu; Allen R Kunselman; Bala V Manyam; Kala Venkiteswaran; Thyagarajan Subramanian
Journal:  Parkinsonism Relat Disord       Date:  2010-05-31       Impact factor: 4.891

Review 4.  Case of levodopa toxicity from ingestion of Mucuna gigantea.

Authors:  Gary G Tse; Brian B Kim; Aaron M McMurtray; Beau K Nakamoto
Journal:  Hawaii J Med Public Health       Date:  2013-05

5.  The history of Parkinson's disease: early clinical descriptions and neurological therapies.

Authors:  Christopher G Goetz
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

Review 6.  A review: traditional herbs and remedies impacting pathogenesis of Parkinson's disease.

Authors:  Vishavdeep Sharma; Onkar Bedi; Manisha Gupta; Rahul Deshmukh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-03-08       Impact factor: 3.000

Review 7.  Mucuna pruriens in Parkinson's and in some other diseases: recent advancement and future prospective.

Authors:  Sachchida Nand Rai; Vivek K Chaturvedi; Payal Singh; Brijesh Kumar Singh; M P Singh
Journal:  3 Biotech       Date:  2020-11-10       Impact factor: 2.406

8.  Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease.

Authors:  Sanjay Kasture; Silvia Pontis; Annalisa Pinna; Nicoletta Schintu; Liliana Spina; Rosanna Longoni; Nicola Simola; Mauro Ballero; Micaela Morelli
Journal:  Neurotox Res       Date:  2009-02-20       Impact factor: 3.911

9.  Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.

Authors:  R Katzenschlager; A Evans; A Manson; P N Patsalos; N Ratnaraj; H Watt; L Timmermann; R Van der Giessen; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

Review 10.  Estrogenic Plants: to Prevent Neurodegeneration and Memory Loss and Other Symptoms in Women After Menopause.

Authors:  Valentina Echeverria; Florencia Echeverria; George E Barreto; Javier Echeverría; Cristhian Mendoza
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.